FDA Approves Wellbutrin XL(R) (bupropion HCl Extended-release Tablets) For The Prevention Of Seasonal Major Depressive Episodes

... The U.S. Food andDrug Administration (FDA) has approved Wellbutrin XL(R) for the preventionof seasonal major depressive episodes in patients with a diagnosis ofseasonal affective disorder (SAD), a condition affecting about 6 percent ofAmerican adults. Wellbutrin XL is the first and only medication approved toprevent seasonal major depressive episodes. [click link for full article] ...